Nyxoah Discloses Shareholder Declarations Following IPO
Nyxoah SA has published significant shareholder declarations following its initial public offering. The disclosures pertain to holdings by Jürgen Hambrecht, Together Partnership, Cochlear Limited, and Robert Taub.
Mont-Saint-Guibert, Belgium – Nyxoah SA, a medical device company focused on sleep apnea solutions, has announced the publication of significant shareholder declarations following its initial public offering (IPO). The disclosures were made in compliance with Belgium's transparency laws regarding substantial shareholdings.
The declarations, dated September 30, 2020, detail share allocations as of September 18, 2020, the first day of trading on Euronext Brussels. These figures account for shares subscribed and admitted to trading on a 'when-issued' basis prior to the IPO's closing date of September 21, 2020.
Key disclosures include Jürgen Hambrecht holding 1,047,029 shares (4.89% of voting rights) and Together Partnership holding 2,503,500 shares (11.69% of voting rights).
Additionally, Cochlear Limited, via its subsidiary Cochlear Investments Pty Ltd, declared a holding of 3,947,617 shares, representing 18.43% of voting rights. Robert Taub, along with entities Robelga SRL, Ronata, and MINV SA, reported a combined holding of 2,817,470 shares, equating to 13.15% of voting rights.
The published information outlines the number of voting rights and their percentage relative to the total number of voting rights in Nyxoah SA.